Gas-filled stabilized particles and methods of use
US-10577554-B2 · Mar 3, 2020 · US
US11147890B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11147890-B2 |
| Application number | US-201816489541-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 28, 2018 |
| Priority date | Feb 28, 2017 |
| Publication date | Oct 19, 2021 |
| Grant date | Oct 19, 2021 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Provided herein are various gas-filled particles having a stimuli-responsive shell encapsulating the gas. The stimuli-responsive shell comprises one or more release triggers. Compositions for medical or non-medical applications, methods of use and treatment, and methods of preparation are also described.
Opening claim text (preview).
We claim: 1. A composition comprising a stable particle having a shell surrounding a gas core, wherein the shell includes a release trigger, wherein the release trigger is a pH-responsive trigger, wherein the shell comprises succinylated and acetylated dextran (Dex-Ac-Suc), and wherein the succinyl moiety of the Dex-Ac-Suc is the pH-responsive trigger. 2. The composition of claim 1 , wherein the shell comprises nanoparticle aggregates. 3. The composition of claim 2 , wherein the stable particle is formed by nanoprecipitation of an amphiphilic polymer comprising the release trigger at an air/liquid interface to form the shell. 4. The composition of claim 3 , wherein the amphiphilic polymer comprises acetylated dextran (Dex-Ac). 5. The composition of claim 2 , wherein the nanoparticle aggregates comprise primary particles, each primary particle having an average diameter of 50 nm or less, and wherein the shell has a thickness of 10-280 nm. 6. The composition of claim 1 , wherein the stable particle is formed by nanoprecipitation of an amphiphilic polymer comprising the release trigger at an air/liquid interface to form the shell.
Medicinal preparations containing inorganic active ingredients · CPC title
Drugs for disorders of the blood or the extracellular fluid · CPC title
Solutions {(composition of solutions A61K47/00)} · CPC title
Polysaccharides, e.g. alginate, chitosan, cellulose derivatives; Cyclodextrin · CPC title
Microbubbles, hollow microspheres, free gas bubbles, gas microspheres · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.